Amalgamated Bank’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-31,352
Closed -$20K 3247
2022
Q1
$20K Sell
31,352
-2,452
-7% -$1.89K ﹤0.01% 2814
2021
Q4
$38K Sell
33,804
-1,167
-3% -$1.8K ﹤0.01% 2126
2021
Q3
$65K Sell
34,971
-1,429
-4% -$3.21K ﹤0.01% 2117
2021
Q2
$115K Buy
+36,400
New +$91K ﹤0.01% 2105
2019
Q4
Sell
-2,377
Closed -$19K 1844
2019
Q3
$19K Sell
2,377
-22
-0.9% -$299 ﹤0.01% 1759
2019
Q2
$42K Buy
2,399
+505
+27% +$11.1K ﹤0.01% 1764
2019
Q1
$59K Buy
1,894
+64
+3% +$2.15K ﹤0.01% 1636
2018
Q4
$54K Buy
+1,830
New +$83.2K ﹤0.01% 1559
2018
Q3
Sell
-1,827
Closed -$104K 1642
2018
Q2
$104K Buy
+1,827
New +$66.5K ﹤0.01% 1654

Other funds holding ASXC

Amalgamated Bank's ASXC Position: Q2 2022 in Review

Amalgamated Bank sold out of Asensus Surgical, Inc. (ASXC) in Q2 2022, closing a stake of 31,352 shares — an estimated $20K sold.

Amalgamated Bank first reported a position in ASXC in Q2 2018 and held it in 9 quarters. The position peaked at $115K in Q2 2021. 91 funds tracked by Wall St. Rank hold ASXC as of Q2 2022.

  • Amalgamated Bank reported no remaining Asensus Surgical, Inc. position as of Q2 2022 after selling out during the quarter.
  • Amalgamated Bank sold 31,352 Asensus Surgical, Inc. shares in Q2 2022, an estimated $20K.
  • Amalgamated Bank first reported a position in Asensus Surgical, Inc. in Q2 2018 and held it in 9 quarters.
  • Amalgamated Bank's Asensus Surgical, Inc. position peaked at $115K in Q2 2021.
  • 91 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.